Related Experiment Video
Updated: Jun 12, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
[Infant botulism]
Thomas Hoffmann1, Kåre Mølbak, Anders Paerregaard
1Børneafdelingen, Hvidovre Hospital, 2650 Hvidovre, Denmark. thoffmann@dadlnet.dk
Insights
Infant botulism, a rare condition in infants under 12 months, results from Clostridium botulinum toxins. Early diagnosis and supportive care, including antitoxins, are crucial for managing this descending paralysis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neurology
Abstract:
Infant botulism is a rare disease that affects infants below the age of 12 months following absorption of neurotoxins produced by ingested Clostridium botulinum spores. The clinical manifestations are caused by symmetrical cranial nerve palsies followed by descending, symmetric flaccid paralysis of voluntary muscles. Presenting symptoms include constipation, lethargy, mydriasis and ptosis. The diagnosis is made on the basis of clinical examination and confirmed by isolating the toxin in serum or stools. Treatment consists of supportive intensive care and treatment with antitoxins.
Related Concept Videos
Botulism
Tetanus
Pyloric Obstruction
Bacterial Gastroenteritis
Bacterial Toxins
Bacterial Meningitis

